IDEXX LABORATORIES INC /DE Payments to Acquire Debt Securities, Available-for-sale
IDEXX LABORATORIES INC /DE (IDXX) reported Payments to Acquire Debt Securities, Available-for-sale of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-02-12.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt · last filed 2021-02-12
- IDEXX LABORATORIES INC /DE payments to acquire debt securities, available-for-sale for the quarter ending 2019-12-31 was $0.00.
- IDEXX LABORATORIES INC /DE payments to acquire debt securities, available-for-sale for the quarter ending 2019-09-30 was $0.00.
- IDEXX LABORATORIES INC /DE payments to acquire debt securities, available-for-sale for the quarter ending 2019-06-30 was $0.00.
- IDEXX LABORATORIES INC /DE payments to acquire debt securities, available-for-sale for the quarter ending 2019-03-31 was $0.00, a 100.00% decline year-over-year.
- IDEXX LABORATORIES INC /DE payments to acquire debt securities, available-for-sale for fiscal 2020 was $0.00.
- IDEXX LABORATORIES INC /DE payments to acquire debt securities, available-for-sale for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- IDEXX LABORATORIES INC /DE payments to acquire debt securities, available-for-sale for fiscal 2018 was $87.00K, a 99.97% decline from fiscal 2017.
- IDEXX LABORATORIES INC /DE payments to acquire debt securities, available-for-sale for fiscal 2017 was $334.16M, a 46.63% increase from fiscal 2016.
| Period end | Payments to Acquire Debt Securities, Available-for-sale 3 month | Payments to Acquire Debt Securities, Available-for-sale 6 month | Payments to Acquire Debt Securities, Available-for-sale 9 month | Payments to Acquire Debt Securities, Available-for-sale 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-02-12 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12 | $0.00 derived: sum of 2 quarters · filed 2021-02-12 | $0.00 derived: sum of 3 quarters · filed 2021-02-12 | $0.00 10-K · filed 2021-02-12 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $0.00 derived: sum of 2 quarters · filed 2019-10-31 | $0.00 10-Q · filed 2019-10-31 | $0.00 derived: sum of 4 quarters · filed 2021-02-12 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $0.00 10-Q · filed 2019-08-01 | $0.00 derived: sum of 3 quarters · filed 2021-02-12 | $0.00 derived: sum of 4 quarters · filed 2021-02-12 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-01 | $0.00 derived: sum of 2 quarters · filed 2021-02-12 | $0.00 derived: sum of 3 quarters · filed 2021-02-12 | $0.00 derived: sum of 4 quarters · filed 2021-02-12 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12 | $0.00 derived: sum of 2 quarters · filed 2021-02-12 | $0.00 derived: sum of 3 quarters · filed 2021-02-12 | $87.00K 10-K · filed 2021-02-12 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $0.00 derived: sum of 2 quarters · filed 2019-10-31 | $87.00K 10-Q · filed 2019-10-31 | $64.45M derived: sum of 4 quarters · filed 2020-02-14 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $87.00K 10-Q · filed 2019-08-01 | $64.45M derived: sum of 3 quarters · filed 2020-02-14 | $158.73M derived: sum of 4 quarters · filed 2020-02-14 |
| 2018-03-31 | $87.00K 10-Q · filed 2019-05-01 | $64.45M derived: sum of 2 quarters · filed 2020-02-14 | $158.73M derived: sum of 3 quarters · filed 2020-02-14 | $243.76M derived: sum of 4 quarters · filed 2020-02-14 |
| 2017-12-31 | $64.37M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-14 | $158.64M derived: sum of 2 quarters · filed 2020-02-14 | $243.67M derived: sum of 3 quarters · filed 2020-02-14 | $334.16M 10-K · filed 2020-02-14 |
| 2017-09-30 | $94.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $179.31M derived: sum of 2 quarters · filed 2018-11-01 | $269.80M 10-Q · filed 2018-11-01 | $318.86M derived: sum of 4 quarters · filed 2019-02-15 |
| 2017-06-30 | $85.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $175.52M 10-Q · filed 2018-08-01 | $224.59M derived: sum of 3 quarters · filed 2019-02-15 | $279.61M derived: sum of 4 quarters · filed 2019-02-15 |
| 2017-03-31 | $90.49M 10-Q · filed 2018-05-04 | $139.56M derived: sum of 2 quarters · filed 2019-02-15 | $194.58M derived: sum of 3 quarters · filed 2019-02-15 | $246.31M derived: sum of 4 quarters · filed 2019-02-15 |
| 2016-12-31 | $49.06M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-15 | $104.08M derived: sum of 2 quarters · filed 2019-02-15 | $155.81M derived: sum of 3 quarters · filed 2019-02-15 | $227.89M 10-K · filed 2019-02-15 |
| 2016-09-30 | $55.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | $106.75M derived: sum of 2 quarters · filed 2017-10-31 | $178.83M 10-Q · filed 2017-10-31 | $219.40M derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-06-30 | $51.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | $123.81M 10-Q · filed 2017-08-01 | $164.38M derived: sum of 3 quarters · filed 2018-02-16 | $205.40M derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-03-31 | $72.08M 10-Q · filed 2017-04-28 | $112.65M derived: sum of 2 quarters · filed 2018-02-16 | $153.67M derived: sum of 3 quarters · filed 2018-02-16 | $203.59M derived: sum of 4 quarters · filed 2018-02-16 |
| 2015-12-31 | $40.57M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $81.59M derived: sum of 2 quarters · filed 2018-02-16 | $131.51M derived: sum of 3 quarters · filed 2018-02-16 | $271.96M 10-K · filed 2018-02-16 |
| 2015-09-30 | $41.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | $90.94M derived: sum of 2 quarters · filed 2016-11-01 | $231.39M 10-Q · filed 2016-11-01 | |
| 2015-06-30 | $49.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-02 | $190.37M 10-Q · filed 2016-08-02 | ||
| 2015-03-31 | $140.45M 10-Q · filed 2016-04-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |